Skip to main content
. 2017 Mar 7;8(5):861–869. doi: 10.7150/jca.17957

Figure 1.

Figure 1

Kaplan-Meier overall survival (A), progression-free survival (B), locoregional relapse-free survival (C), and distant metastasis-free survival (D) curves for the 664 patients with nasopharyngeal carcinoma divided into the residual tumor group and non-residual tumor group. All categories are based on the 7th edition of the Union for International Cancer Control/American Joint Committee on Cancer staging system.